People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Avotres Inc. | — | Biotechnology | Seed | $8.0M | $36.9M | 2023 |
| CorMedix Inc. | — | Pharmaceuticals | Seed | $3.5M | $32.3M | 2009 |
Bruce Cooper at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bruce Cooper on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Houghton | 2 | 2 |
| Biao He | 1 | 5 |
| RIchard M. Cohen | 1 | 3 |
| Stephen Pilatzke | 1 | 2 |
| Antony Pfaffle | 1 | 2 |
| Alex Li | 1 | 2 |
| Lindsay Rosenwald | 1 | 2 |
| Timothy Hofer | 1 | 2 |
| Mark Houser | 1 | 1 |
| Dan Zhao | 1 | 1 |
| Zhongping Sun | 1 | 1 |
| Yan Lei | 1 | 1 |
| Zihao Zou | 1 | 1 |
| Russell Ellison | 1 | 1 |
| Anthony E. Pfaffle | 1 | 1 |
| Matthew W. Duffy | 1 | 1 |
| Steven W. Lefkowitz | 1 | 1 |
| Timothy A. Hofer | 1 | 1 |
| Gary A. Gelbfish | 1 | 1 |
| Randy W. Milby | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.